Clinical impact of COVID-19 on a French population of spondyloarthritis patients
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Rheumatology
Link
https://link.springer.com/content/pdf/10.1007/s10067-020-05413-9.pdf
Reference6 articles.
1. FitzGerald GA (2020) Misguided drug advice for COVID-19. Science 367:1434
2. Giollo A, Adami G, Gatti D, Luca I, Rossini M (2020) Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID). Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2020-217598
3. Jethwa H, Sullivan A, Abraham S (2020) COVID-19 and rheumatology patients on immunomodulatory therapy - can we extrapolate data from previous viral pandemics? J Rheumatol. https://doi.org/10.3899/jrheum.200527
4. Mikuls TR, Johnson SR, Fraenkel L, Arasaratnam RJ, Baden LR, Bermas BL, Chatham W, Cohen S, Costenbader K, Gravallese EM, Kalil AC, Weinblatt ME, Winthrop K, Mudano AS, Turner A, Saag KG (2020) American College of Rheumatology guidance for the management of adult patients with rheumatic disease during the COVID-19 pandemic. Arthritis Rheum 72:1241–1251. https://doi.org/10.1002/art.41301
5. Monti S, Balduzzi S, Delvino P, Bellis E, Quadrelli VS, Montecucco C (2020) Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann Rheum Dis 79:667–668
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. COVID-19 et rhumatismes inflammatoires chroniques de l’adulte : le point après les vagues successives;Revue du Rhumatisme;2023-10
2. Poor health and functioning in patients with axial spondyloarthritis during the COVID-19 pandemic and lockdown: REUMAVID study (phase 1);Therapeutic Advances in Musculoskeletal Disease;2022-01
3. Microorganisms in the Pathogenesis and Management of Spondyloarthritis;Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3